{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:50:45Z","timestamp":1791845445040,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.revmed.2025.05.011","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T22:09:18Z","timestamp":1749161358000},"page":"482-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hydroxychloroquine dans le lupus \u00e9ryth\u00e9mateux syst\u00e9mique\u00a0: principales mises \u00e0 jour"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-903X","authenticated-orcid":false,"given":"Ludovic","family":"Trefond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.revmed.2025.05.011_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023\u00a0update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.revmed.2025.05.011_bib0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.revmed.2024.07.006","article-title":"French protocol for the diagnosis and management of systemic lupus erythematosus","volume":"45","author":"Amoura","year":"2024","journal-title":"Rev Med Interne"},{"issue":"1S","key":"10.1016\/j.revmed.2025.05.011_bib0150","first-page":"S1","article-title":"KDIGO 2024\u00a0Clinical Practice Guideline for the management of LUPUS NEPHRITIS","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"14","key":"10.1016\/j.revmed.2025.05.011_bib0155","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.2022.13591","article-title":"Hydroxychloroquine dose per ophthalmology guidelines and the risk of systemic lupus erythematosus flares","volume":"328","author":"Jorge","year":"2022","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.revmed.2025.05.011_bib0160","first-page":"1512","article-title":"Hydroxychloroquine dose and hospitalizations for active lupus","volume":"76","author":"Nestor","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.revmed.2025.05.011_bib0165","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/art.42645","article-title":"Association between severe non-adherence to hydroxychloroquine and SLE flares, damage, and mortality in 660 patients from the SLICC Inception Cohort","volume":"75","author":"Nguyen","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2025.05.011_bib0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/annrheumdis-2021-221295","article-title":"Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort","volume":"81","author":"Almeida-Brasil","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.revmed.2025.05.011_bib0175","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/art.41121","article-title":"Hydroxychloroquine blood levels predict hydroxychloroquine retinopathy","volume":"72","author":"Petri","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2025.05.011_bib0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7326\/M22-2453","article-title":"Hydroxychloroquine dose and risk for incident retinopathy: a cohort study","volume":"176","author":"Melles","year":"2023","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.revmed.2025.05.011_bib0185","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016\u00a0Revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.revmed.2025.05.011_bib0190","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.revmed.2025.05.011_bib0195","doi-asserted-by":"crossref","first-page":"152417","DOI":"10.1016\/j.semarthrit.2024.152417","article-title":"Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients","volume":"66","author":"Trefond","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.revmed.2025.05.011_bib0200","doi-asserted-by":"crossref","first-page":"e2410677","DOI":"10.1001\/jamanetworkopen.2024.10677","article-title":"Risk factors for hydroxychloroquine retinopathy and its subtypes","volume":"7","author":"Jorge","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.revmed.2025.05.011_bib0205","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00417-024-06461-6","article-title":"Factors associated with early hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus","volume":"262","author":"Ara\u00fajo","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.revmed.2025.05.011_bib0210","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ceo.14461","article-title":"Mimickers of hydroxychloroquine retinal toxicity","volume":"52","author":"Jones","year":"2024","journal-title":"Clin Experiment Ophthalmol"},{"issue":"6","key":"10.1016\/j.revmed.2025.05.011_bib0215","doi-asserted-by":"crossref","first-page":"105756","DOI":"10.1016\/j.jbspin.2024.105756","article-title":"Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal","volume":"91","author":"Trefond","year":"2024","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.revmed.2025.05.011_bib0220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/ard.2006.067835","article-title":"Hulot J-S, et al. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus","volume":"66","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.revmed.2025.05.011_bib0225","doi-asserted-by":"crossref","first-page":"e001090","DOI":"10.1136\/lupus-2023-001090","article-title":"Interpreting hydroxychloroquine blood levels for medication non-adherence: a pharmacokinetic study","volume":"11","author":"Balevic","year":"2024","journal-title":"Lupus Sci Med"},{"issue":"4","key":"10.1016\/j.revmed.2025.05.011_bib0230","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/ard-2023-225023","article-title":"Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus","volume":"83","author":"Trefond","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.revmed.2025.05.011_bib0235","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/rheumatology\/keae302","article-title":"Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients","volume":"64","author":"Alle","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.revmed.2025.05.011_bib0240","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/art.42793","article-title":"Hydroxychloroquine in lupus pregnancy and risk of preeclampsia","volume":"76","author":"Rector","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2025.05.011_bib0245","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/rheumatology\/kead384","article-title":"British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine","volume":"63","author":"Russell","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2025.05.011_bib0250","unstructured":"FAI2R, la SFR, la SNFMI, la SFD, sous l\u2019\u00e9gide du CRI. Hyroxychloroquine contraception grossesse allaitement [Internet]. Prise Encharge Prat. Patients sous hydroxychloroquine. [cited 2024\u00a0December 26]; available from: https:\/\/drive.google.com\/file\/d\/1BvPGzJbn12GRQZGy16Ro9qz9cSDIj8ih\/view?usp=embed_facebook."},{"issue":"9","key":"10.1016\/j.revmed.2025.05.011_bib0255","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/S2665-9913(23)00215-1","article-title":"Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases","volume":"5","author":"Schreiber","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2025.05.011_bib0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/rheumatology\/keae168","article-title":"Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study","volume":"64","author":"Nguyen","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2025.05.011_bib0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2023.02.004","article-title":"Mortality and causes of death in systemic lupus erythematosus over the last decade: data from a large population-based study","volume":"112","author":"Zen","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.revmed.2025.05.011_bib0270","doi-asserted-by":"crossref","first-page":"e2432190","DOI":"10.1001\/jamanetworkopen.2024.32190","article-title":"Hydroxychloroquine and cardiovascular events in patients with systemic lupus erythematosus","volume":"7","author":"Grimaldi","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325006228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325006228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:41:57Z","timestamp":1754635317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866325006228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0248866325006228"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2025.05.011","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine dans le lupus \u00e9ryth\u00e9mateux syst\u00e9mique\u00a0: principales mises \u00e0 jour","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2025.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}